Boston Partners Long/Short Research Fund Inv (BPRRX)
13.46
+0.09
(+0.67%)
USD |
May 16 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 2.15% | 521.39M | -- | 53.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -85.01M | 8.45% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital apprecThe Fund will invest, both long and short, in equity securities issued by large-, mid- and small-cap companies, as well as other instruments that are convertible into equity securities. The Fund may invest in securities of companies operating for three years or less. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Alternative Long/Short Equity US |
| Peer Group | Alternative Long/Short Equity Funds |
| Global Macro | Alternative Equity |
| US Macro | Alternative Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Alternative Long/Short Equity Funds |
| Fund Owner Firm Name | Boston Partners |
| Broad Asset Class Benchmark Index | |
| ^MSACWINTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
98
-198.73M
Peer Group Low
440.37M
Peer Group High
1 Year
% Rank:
93
-85.01M
-223.70M
Peer Group Low
2.454B
Peer Group High
3 Months
% Rank:
98
-120.50M
Peer Group Low
1.166B
Peer Group High
3 Years
% Rank:
96
-644.94M
Peer Group Low
3.711B
Peer Group High
6 Months
% Rank:
100
-102.98M
Peer Group Low
1.939B
Peer Group High
5 Years
% Rank:
100
-1.557B
Peer Group Low
3.483B
Peer Group High
YTD
% Rank:
98
-144.91M
Peer Group Low
1.497B
Peer Group High
10 Years
% Rank:
100
-6.515B
Peer Group Low
6.460B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 17, 2025.
Asset Allocation
As of November 30, 2024.
| Type | % Net |
|---|---|
| Cash | 23.33% |
| Stock | 76.83% |
| Bond | 0.13% |
| Convertible | 0.00% |
| Preferred | -0.24% |
| Other | -0.07% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
CASH AND CASH EQUIVALENTS
|
19.56% | -- | -- |
|
USD CASH
|
3.57% | -- | -- |
| Wells Fargo & Co | 1.40% | 76.18 | 0.78% |
| UnitedHealth Group Inc | 1.38% | 291.91 | 6.40% |
| JPMorgan Chase & Co | 1.31% | 267.56 | 0.03% |
| AbbVie Inc | 1.18% | 184.02 | 1.29% |
| Alphabet Inc | 1.13% | 166.19 | 1.36% |
| Booking Holdings Inc | 0.90% | 5317.07 | 1.51% |
| US Foods Holding Corp | 0.87% | 76.63 | 1.10% |
| Bank of America Corp | 0.86% | 44.69 | 0.70% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 1.25% |
| Administration Fee | 2.30K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors | No |
| Minimum Initial Investment | 2500.00 None |
| Minimum Subsequent Investment | 100.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital apprecThe Fund will invest, both long and short, in equity securities issued by large-, mid- and small-cap companies, as well as other instruments that are convertible into equity securities. The Fund may invest in securities of companies operating for three years or less. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | Alternative |
| Broad Category | Alternative |
| Global Peer Group | Alternative Long/Short Equity US |
| Peer Group | Alternative Long/Short Equity Funds |
| Global Macro | Alternative Equity |
| US Macro | Alternative Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Alternative Long/Short Equity Funds |
| Fund Owner Firm Name | Boston Partners |
| Broad Asset Class Benchmark Index | |
| ^MSACWINTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (5-16-25) | 0.71% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 25.41 |
| Weighted Average Price to Sales Ratio | 3.442 |
| Weighted Average Price to Book Ratio | 5.353 |
| Weighted Median ROE | 295.6% |
| Weighted Median ROA | 6.36% |
| ROI (TTM) | 12.85% |
| Return on Investment (TTM) | 12.85% |
| Earning Yield | 0.0541 |
| LT Debt / Shareholders Equity | 1.597 |
As of November 30, 2024
Growth Metrics
| EPS Growth (1Y) | 12.67% |
| EPS Growth (3Y) | 23.59% |
| EPS Growth (5Y) | 13.55% |
| Sales Growth (1Y) | 5.09% |
| Sales Growth (3Y) | 12.93% |
| Sales Growth (5Y) | 8.61% |
| Sales per Share Growth (1Y) | 7.22% |
| Sales per Share Growth (3Y) | 13.75% |
| Operating Cash Flow - Growth Ratge (3Y) | 20.46% |
As of November 30, 2024
Fund Details
| Key Dates | |
| Inception Date | 11/29/2010 |
| Last Annual Report Date | 8/31/2024 |
| Last Prospectus Date | 12/31/2024 |
| Share Classes | |
| BPIRX | Inst |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:BPRRX", "name") |
| Broad Asset Class: =YCI("M:BPRRX", "broad_asset_class") |
| Broad Category: =YCI("M:BPRRX", "broad_category_group") |
| Prospectus Objective: =YCI("M:BPRRX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |